EW logo

Edwards Lifesciences (EW) Cash from investing

annual CFI:

$2.31B+$2.14B(+1230.78%)
December 31, 2024

Summary

  • As of today (June 22, 2025), EW annual cash flow from investing activities is $2.31 billion, with the most recent change of +$2.14 billion (+1230.78%) on December 31, 2024.
  • During the last 3 years, EW annual CFI has risen by +$4.04 billion (+234.28%).
  • EW annual CFI is now at all-time high.

Performance

EW Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

quarterly CFI:

$85.30M+$662.00M(+114.79%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW quarterly cash flow from investing activities is $85.30 million, with the most recent change of +$662.00 million (+114.79%) on March 1, 2025.
  • Over the past year, EW quarterly CFI has increased by +$22.20 million (+35.18%).
  • EW quarterly CFI is now -96.84% below its all-time high of $2.70 billion, reached on September 30, 2024.

Performance

EW quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

TTM CFI:

$2.34B+$22.20M(+0.96%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW TTM cash flow from investing activities is $2.34 billion, with the most recent change of +$22.20 million (+0.96%) on March 1, 2025.
  • Over the past year, EW TTM CFI has increased by +$2.10 billion (+887.77%).
  • EW TTM CFI is now -19.58% below its all-time high of $2.90 billion, reached on September 30, 2024.

Performance

EW TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

EW Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1230.8%+35.2%+887.8%
3 y3 years+234.3%-62.8%+261.8%
5 y5 years+488.2%+163.3%+442.9%

EW Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+234.3%-96.8%+114.8%-19.6%+261.8%
5 y5-yearat high+234.3%-96.8%+108.8%-19.6%+235.6%
alltimeall timeat high+234.3%-96.8%+108.8%-19.6%+235.6%

EW Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$85.30M(-114.8%)
$2.34B(+1.0%)
Dec 2024
$2.31B(+1230.8%)
-$576.70M(-121.3%)
$2.31B(-20.3%)
Sep 2024
-
$2.70B(+2064.8%)
$2.90B(+897.8%)
Jun 2024
-
$124.80M(+97.8%)
$291.00M(+23.1%)
Mar 2024
-
$63.10M(+347.5%)
$236.40M(+36.0%)
Dec 2023
$173.80M(-31.1%)
$14.10M(-84.2%)
$173.80M(-31.7%)
Sep 2023
-
$89.00M(+26.8%)
$254.40M(-804.7%)
Jun 2023
-
$70.20M(>+9900.0%)
-$36.10M(-254.9%)
Mar 2023
-
$500.00K(-99.5%)
$23.30M(-90.8%)
Dec 2022
$252.30M(-114.6%)
$94.70M(-147.0%)
$252.30M(-131.2%)
Sep 2022
-
-$201.50M(-255.5%)
-$808.30M(-17.9%)
Jun 2022
-
$129.60M(-43.5%)
-$984.20M(-31.8%)
Mar 2022
-
$229.50M(-123.8%)
-$1.44B(-16.2%)
Dec 2021
-$1.72B(+224.3%)
-$965.90M(+155.9%)
-$1.72B(+69.5%)
Sep 2021
-
-$377.40M(+14.5%)
-$1.02B(+32.8%)
Jun 2021
-
-$329.50M(+563.0%)
-$765.40M(+71.6%)
Mar 2021
-
-$49.70M(-80.9%)
-$446.10M(-16.0%)
Dec 2020
-$531.10M(-10.9%)
-$259.90M(+105.8%)
-$531.10M(-25.9%)
Sep 2020
-
-$126.30M(+1138.2%)
-$716.50M(+18.8%)
Jun 2020
-
-$10.20M(-92.4%)
-$602.90M(-11.5%)
Mar 2020
-
-$134.70M(-69.8%)
-$681.00M(+14.3%)
Dec 2019
-$595.80M(-876.8%)
-$445.30M(+3406.3%)
-$595.80M(+311.5%)
Sep 2019
-
-$12.70M(-85.6%)
-$144.80M(-62.5%)
Jun 2019
-
-$88.30M(+78.4%)
-$386.30M(+100.1%)
Mar 2019
-
-$49.50M(-968.4%)
-$193.10M(-351.8%)
Dec 2018
$76.70M(-111.9%)
$5.70M(-102.2%)
$76.70M(-36.2%)
Sep 2018
-
-$254.20M(-342.3%)
$120.30M(-27.1%)
Jun 2018
-
$104.90M(-52.4%)
$165.00M(-128.5%)
Mar 2018
-
$220.30M(+346.9%)
-$578.10M(-10.7%)
Dec 2017
-$647.20M(+205.7%)
$49.30M(-123.5%)
-$647.20M(+5.0%)
Sep 2017
-
-$209.50M(-67.2%)
-$616.30M(+53.0%)
Jun 2017
-
-$638.20M(-522.1%)
-$402.90M(+273.7%)
Mar 2017
-
$151.20M(+88.5%)
-$107.80M(-49.1%)
Dec 2016
-$211.70M(-33.0%)
$80.20M(+1956.4%)
-$211.70M(-20.0%)
Sep 2016
-
$3.90M(-101.1%)
-$264.60M(-40.4%)
Jun 2016
-
-$343.10M(-825.4%)
-$444.10M(+401.8%)
Mar 2016
-
$47.30M(+73.3%)
-$88.50M(-72.0%)
Dec 2015
-$316.10M(-50.1%)
$27.30M(-115.5%)
-$316.10M(+36.6%)
Sep 2015
-
-$175.60M(-1504.8%)
-$231.40M(+9.9%)
Jun 2015
-
$12.50M(-106.9%)
-$210.60M(-69.6%)
Mar 2015
-
-$180.30M(-261.0%)
-$693.50M(+9.6%)
Dec 2014
-$633.00M(+53.4%)
$112.00M(-172.4%)
-$633.00M(-36.2%)
Sep 2014
-
-$154.80M(-67.1%)
-$991.90M(+5.1%)
Jun 2014
-
-$470.40M(+292.7%)
-$943.60M(+72.8%)
Mar 2014
-
-$119.80M(-51.5%)
-$546.20M(+32.3%)
Dec 2013
-$412.70M(+423.7%)
-$246.90M(+131.8%)
-$412.70M(+198.2%)
Sep 2013
-
-$106.50M(+45.9%)
-$138.40M(-15.5%)
Jun 2013
-
-$73.00M(-632.8%)
-$163.80M(+22.7%)
Mar 2013
-
$13.70M(-50.0%)
-$133.50M(+69.4%)
Dec 2012
-$78.80M
$27.40M(-120.8%)
-$78.80M(-63.3%)
Sep 2012
-
-$131.90M(+208.9%)
-$214.50M(+685.7%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$42.70M(-162.4%)
-$27.30M(-84.8%)
Mar 2012
-
$68.40M(-163.2%)
-$180.00M(-55.7%)
Dec 2011
-$406.50M(+561.0%)
-$108.30M(-295.8%)
-$406.50M(+26.5%)
Sep 2011
-
$55.30M(-128.3%)
-$321.30M(-18.0%)
Jun 2011
-
-$195.40M(+23.6%)
-$391.80M(+83.9%)
Mar 2011
-
-$158.10M(+584.4%)
-$213.10M(+246.5%)
Dec 2010
-$61.50M(-253.4%)
-$23.10M(+52.0%)
-$61.50M(+13.3%)
Sep 2010
-
-$15.20M(-9.0%)
-$54.30M(-482.4%)
Jun 2010
-
-$16.70M(+156.9%)
$14.20M(-12.9%)
Mar 2010
-
-$6.50M(-59.1%)
$16.30M(-59.4%)
Dec 2009
$40.10M(-31.8%)
-$15.90M(-129.8%)
$40.10M(+2.3%)
Sep 2009
-
$53.30M(-465.1%)
$39.20M(-340.5%)
Jun 2009
-
-$14.60M(-184.4%)
-$16.30M(+139.7%)
Mar 2009
-
$17.30M(-203.0%)
-$6.80M(-111.6%)
Dec 2008
$58.80M(-140.7%)
-$16.80M(+663.6%)
$58.80M(-443.9%)
Sep 2008
-
-$2.20M(-56.9%)
-$17.10M(-41.6%)
Jun 2008
-
-$5.10M(-106.2%)
-$29.30M(-26.8%)
Mar 2008
-
$82.90M(-189.4%)
-$40.00M(-72.3%)
Dec 2007
-$144.50M(+304.8%)
-$92.70M(+543.8%)
-$144.50M(+144.1%)
Sep 2007
-
-$14.40M(-8.9%)
-$59.20M(-2.1%)
Jun 2007
-
-$15.80M(-26.9%)
-$60.50M(+15.9%)
Mar 2007
-
-$21.60M(+191.9%)
-$52.20M(+46.2%)
Dec 2006
-$35.70M(+31.3%)
-$7.40M(-52.9%)
-$35.70M(-3.8%)
Sep 2006
-
-$15.70M(+109.3%)
-$37.10M(+12.4%)
Jun 2006
-
-$7.50M(+47.1%)
-$33.00M(-6.0%)
Mar 2006
-
-$5.10M(-42.0%)
-$35.10M(+29.0%)
Dec 2005
-$27.20M(-84.6%)
-$8.80M(-24.1%)
-$27.20M(-26.3%)
Sep 2005
-
-$11.60M(+20.8%)
-$36.90M(-16.3%)
Jun 2005
-
-$9.60M(-442.9%)
-$44.10M(+5.3%)
Mar 2005
-
$2.80M(-115.1%)
-$41.90M(-76.3%)
Dec 2004
-$177.10M(+130.3%)
-$18.50M(-1.6%)
-$177.10M(-8.0%)
Sep 2004
-
-$18.80M(+154.1%)
-$192.50M(+3.4%)
Jun 2004
-
-$7.40M(-94.4%)
-$186.10M(+0.5%)
Mar 2004
-
-$132.40M(+290.6%)
-$185.10M(+140.7%)
Dec 2003
-$76.90M(+12.6%)
-$33.90M(+173.4%)
-$76.90M(-6.9%)
Sep 2003
-
-$12.40M(+93.8%)
-$82.60M(+2.4%)
Jun 2003
-
-$6.40M(-73.6%)
-$80.70M(-5.1%)
Mar 2003
-
-$24.20M(-38.9%)
-$85.00M(+24.5%)
Dec 2002
-$68.30M(+1607.5%)
-$39.60M(+277.1%)
-$68.30M(+68.2%)
Sep 2002
-
-$10.50M(-1.9%)
-$40.60M(-9.6%)
Jun 2002
-
-$10.70M(+42.7%)
-$44.90M(-2463.2%)
Mar 2002
-
-$7.50M(-37.0%)
$1.90M(-147.5%)
Dec 2001
-$4.00M(-94.7%)
-$11.90M(-19.6%)
-$4.00M(+48.1%)
Sep 2001
-
-$14.80M(-141.0%)
-$2.70M(-131.0%)
Jun 2001
-
$36.10M(-369.4%)
$8.70M(-114.2%)
Mar 2001
-
-$13.40M(+26.4%)
-$61.40M(-18.1%)
Dec 2000
-$75.00M(+53.1%)
-$10.60M(+211.8%)
-$75.00M(+16.5%)
Sep 2000
-
-$3.40M(-90.0%)
-$64.40M(+5.6%)
Jun 2000
-
-$34.00M(+25.9%)
-$61.00M(+125.9%)
Mar 2000
-
-$27.00M
-$27.00M
Dec 1999
-$49.00M
-
-

FAQ

  • What is Edwards Lifesciences annual cash flow from investing activities?
  • What is the all time high annual CFI for Edwards Lifesciences?
  • What is Edwards Lifesciences annual CFI year-on-year change?
  • What is Edwards Lifesciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly CFI year-on-year change?
  • What is Edwards Lifesciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM CFI year-on-year change?

What is Edwards Lifesciences annual cash flow from investing activities?

The current annual CFI of EW is $2.31B

What is the all time high annual CFI for Edwards Lifesciences?

Edwards Lifesciences all-time high annual cash flow from investing activities is $2.31B

What is Edwards Lifesciences annual CFI year-on-year change?

Over the past year, EW annual cash flow from investing activities has changed by +$2.14B (+1230.78%)

What is Edwards Lifesciences quarterly cash flow from investing activities?

The current quarterly CFI of EW is $85.30M

What is the all time high quarterly CFI for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly cash flow from investing activities is $2.70B

What is Edwards Lifesciences quarterly CFI year-on-year change?

Over the past year, EW quarterly cash flow from investing activities has changed by +$22.20M (+35.18%)

What is Edwards Lifesciences TTM cash flow from investing activities?

The current TTM CFI of EW is $2.34B

What is the all time high TTM CFI for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM cash flow from investing activities is $2.90B

What is Edwards Lifesciences TTM CFI year-on-year change?

Over the past year, EW TTM cash flow from investing activities has changed by +$2.10B (+887.77%)
On this page